Amyloid pterygium of left eye
ICD-10 H11.012 is a billable code used to indicate a diagnosis of amyloid pterygium of left eye.
Amyloid pterygium of the left eye is a rare ocular condition characterized by the deposition of amyloid protein in the conjunctiva, leading to a yellowish-white, gelatinous appearance on the eye's surface. This condition primarily affects the conjunctiva but can also involve the sclera and cornea, resulting in potential visual disturbances. Clinically, patients may present with asymptomatic lesions or experience irritation and cosmetic concerns. The disease progression is typically slow, and while it is not known to be malignant, it can cause discomfort and may interfere with vision if it encroaches on the cornea. Diagnostic considerations include a thorough ocular examination, and in some cases, a biopsy may be performed to confirm the presence of amyloid deposits. Differential diagnoses include other conjunctival lesions such as conjunctival cysts or papillomas. Early identification and monitoring are essential to manage symptoms and prevent complications.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H11.012 specifically covers amyloid pterygium of the left eye, characterized by amyloid deposits in the conjunctiva. It is important to differentiate it from other conjunctival lesions such as conjunctival cysts or neoplasms.
H11.012 should be used when there is a confirmed diagnosis of amyloid pterygium specifically affecting the left eye. It is crucial to use this code when the condition is documented as such, rather than using more general codes for conjunctival disorders.
Documentation should include a detailed ocular examination, clinical findings, and, if applicable, results from a biopsy confirming amyloid deposits. Clear notes on the patient's symptoms and the impact on vision are also essential.
